Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies

INTRODUCTION: In a previous pooled analysis of 19 double-blind clinical studies conducted by Merck, which included data available as of July 2009 on 10,246 patients with type 2 diabetes (T2DM), treatment with sitagliptin was shown to be generally well tolerated compared with treatment with control a...

Descripción completa

Detalles Bibliográficos
Autores principales: Engel, Samuel S., Round, Elizabeth, Golm, Gregory T., Kaufman, Keith D., Goldstein, Barry J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687098/
https://www.ncbi.nlm.nih.gov/pubmed/23700194
http://dx.doi.org/10.1007/s13300-013-0024-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687098/
https://www.ncbi.nlm.nih.gov/pubmed/23700194
http://dx.doi.org/10.1007/s13300-013-0024-0

Ejemplares similares